Regular Internet Use in Late Adulthood May Protect Against Dementia
FRIDAY, May 5, 2023 (HealthDay News) — Being a regular internet user for longer periods in late adulthood is associated with delayed cognitive impairment, according to a study published online May 3 in the Journal of the American Geriatrics Society.G…
Learn MoreIntensive BP Targets Cut Risk for Cardiac Conduction Disease
FRIDAY, May 5, 2023 (HealthDay News) — Intensive blood pressure control is associated with a lower risk for left ventricular conduction disease, according to a study published online May 3 in JAMA Cardiology.Emilie K. Frimodt-Møller, M.D., from the U…
Learn MoreLong-Term Air Pollution Exposure Tied to More Diagnostic Testing in Heart Failure
FRIDAY, May 5, 2023 (HealthDay News) — Long-term exposure to fine airborne particles
Learn MorePoor-Quality Diet Tied to Higher Risk for Adverse CAD, PAD Outcomes
FRIDAY, May 5, 2023 (HealthDay News) — Poor diet quality is independently associated with a higher risk for recurrent major adverse cardiovascular events (MACE) and major adverse limb events (MALE) in patients with chronic coronary artery disease (CA…
Learn MorePrednisone Does Not Improve In Vitro Fertilization Outcomes
FRIDAY, May 5, 2023 (HealthDay News) — Among patients with recurrent implantation failure during in vitro fertilization, treatment with prednisone does not improve the live birth rate versus placebo, according to a study published in the May 2 issue …
Learn MoreLong-Term Indwelling Urethral Catheter Tied to More Infections
FRIDAY, May 5, 2023 (HealthDay News) — Long-term indwelling urethral catheter (IUC) use is associated with a higher incidence of urinary tract infection (UTI) in people with spinal cord injury, according to a study published online March 27 in the Jo…
Learn MoreFDA Approves Lumryz for Narcolepsy
THURSDAY, May 4, 2023 (HealthDay News) — The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to…
Learn MoreIn Survey, Half of U.S. Parents Believe Social Media Is Harming Their Children
WEDNESDAY, May 3, 2023 (HealthDay News) — Half of U.S. parents think social media is bad for their children’s mental health, a new survey reveals.The finding highlights growing concerns about how these platforms affect children’s and adolescents’ wel…
Learn MoreExperimental Drug for Alzheimer Disease Slows Decline in Thinking
WEDNESDAY, May 3, 2023 (HealthDay News) — Another experimental drug meant for Alzheimer disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.Known as donanemab, th…
Learn MoreFDA Approves First RSV Vaccine
WEDNESDAY, May 3, 2023 (HealthDay News) — The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 years and older. Arexvy is expected to help prevent lower respirat…
Learn More